Managing Adverse Events Associated with HE Therapies

Ralph J. Riello, PharmD, BCPS, discusses the adverse events associated with hepatic encephalopathy (HE) treatments and the importance of encouraging patients to continue first-line medications despite adverse reactions to prevent HE recurrence.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP: 1.Identifying and Screening for Hepatic Encephalopathy Risk Factors

EP: 2.Achieving Post-Discharge Success: Goals in Hepatic Encephalopathy Care

EP: 3.Implementing Evidence-Based Guidelines for Hepatic Encephalopathy Management

EP: 4.Addressing the Caregiver Burden in Hepatic Encephalopathy Management

EP: 5.Optimizing Care for Newly Diagnosed Hepatic Encephalopathy

EP: 6.Enhancing Hepatic Encephalopathy Care through Pharmacist-Prescriber Collaboration

Now Viewing

EP: 7.Managing Adverse Events Associated with HE Therapies

EP: 8.Integrating Treatment Protocols and Community Pharmacy in HE Management

EP: 9.Promoting Adherence: Strategies for Maintaining HE Therapy

EP: 10.Empowering Pharmacists: Essential Insights for HE Management

EP: 11.Optimizing Transitions of Care for Hepatic Encephalopathy Patients

EP: 12.Collaborative Care: Key Stakeholders in HE Treatment and Recovery

EP: 13.Hepatic Encephalopathy: Critical Insights and Closing Thoughts

Related Videos

Leveraging Technology to Enhance Women’s Health and Access to Care

Staying Current Regarding Available Therapeutic Options and Updates to Treatment Guidelines

Optimizing ADC Supportive Care Prescribing and AE Management With Institutional Workflows

Monitoring Strategies for Managing ADC Toxicities in mBC

Examining the 505(b)(2) Pathway and Implementation into EHR

Managing ADC Toxicities and Infusion Reactions With Supportive Care Strategies

Strategies for Supporting Adherence to Treatment and Evaluating Efficacy

Patient Education When Initiating Treatment for Menopausal Symptoms

Practical Insights for Pharmacists on ADC Administration, Patient Experience, and Supportive Care

Personalizing ADC Therapy in mBC Based on Patient Characteristics and Prior Therapies